![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Gilead Sciences Gears Up for Clinical Trials of Inhaled Remdesivir
Gilead Sciences Gears Up for Clinical Trials of Inhaled Remdesivir
Gilead Sciences has gotten approval from the FDA to launch a phase 1 trial of an inhaled version of its antiviral remdesivir for the earlier treatment of COVID-19 patients.
The drugmaker said it plans to start trials in August.
Upcoming Events
-
21Oct